The Michigan Department of Health and Human Services (MDHHS) is working to improve care and services to those with sickle ...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...
On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) by end of this month - - GLIX1 is positioned to potentially address unmet ...
The SCD is based on the theory that certain foods fuel bacterial overgrowth in your digestive system, promoting inflammation.
State health officials have a new plan on addressing one of Michigan's most prevalent genetic disorders. Michigan Department ...
Objectives To estimate the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and ...
Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug ...